Vamsee Pillalamarri

Vamsee Pillalamarri

Auto-generated profile, based on publicly available information

Vamsee Pillalamarri

McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Genome Research
Verified
Journal Article
Open access
PDF file
SYStephanie Y. Yang
Stephanie Y. Yang
CCChristina Castellani
Christina Castellani
RLRyan J. Longchamps
Ryan J. Longchamps
VPVamsee K. Pillalamarri
Vamsee K. Pillalamarri
BOBrian O'Rourke
Brian O'Rourke
DADan E. Arking
Dan E. Arking
Mitochondrial DNA copy number (mtDNA-CN) is a proxy for mitochondrial function and is associated with aging-related diseases. However, it is unclear how mtDNA-CN measured in blood can reflect diseases that primarily manifest in other tissues. Using the Genotype-Tissue Expression Project, we interrogated relationships between mtDNA-CN measured in whole blood and gene expression from whole blood and 47 additional tissues in 419 individuals. mtDNA-CN was significantly associated with expression of 700 genes in whole blood, including nuclear genes required for mtDNA replication. Significant enrichment was observed for splicing and ubiquitin-mediated proteolysis pathways, as well as target genes for the mitochondrial transcription factor NRF1. In nonblood tissues, there were more significantly associated genes than expected in 30 tissues, suggesting that global gene expression in those tissues is correlated with blood-derived mtDNA-CN. Neurodegenerative disease pathways were significantly associated in multiple tissues, and in an independent data set, the UK Biobank, we observed that higher mtDNA-CN was significantly associated with lower rates of both prevalent (OR = 0.89, CI = 0.83; 0.96) and incident neurodegenerative disease (HR = 0.95, 95% CI = 0.91;0.98). The observation that mtDNA-CN measured in blood is associated with gene expression in other tissues suggests that blood-derived mtDNA-CN can reflect metabolic health across multiple tissues. Identification of key pathways including splicing, RNA binding, and catalysis reinforces the importance of mitochondria in maintaining cellular homeostasis. Finally, validation of the role of mtDNA CN in neurodegenerative disease in a large independent cohort study solidifies the link between blood-derived mtDNA-CN, altered gene expression in multiple tissues, and aging-related disease.

1 December 2012 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
CECarl Ernst
Carl Ernst
CMChristian R Marshall
Christian R Marshall
YSYiping Shen
Yiping Shen
KMKay Metcalfe
Kay Metcalfe
JRJill Rosenfeld
Jill Rosenfeld
MTMichael E Talkowski
Michael E Talkowski
Assessment blood consumption and trauma-associated severe hemorrhage scores are useful for predicting the need for massive transfusion (MT) in severe traum

26 September 2022 in Human Genetics and Genomics Advances
Verified
Journal Article
Open access
VPVamsee Pillalamarri
Vamsee Pillalamarri
WSWen Shi
Wen Shi
CSConrad Say
Conrad Say
SYStephanie Yang
Stephanie Yang
JLJohn Lane
John Lane
DADan E. Arking
Dan E. Arking
Inter-individual variation in the number of copies of the mitochondrial genome, called mitochondrial DNA copy number (mtDNA-CN), reflects mitochondrial function and has been associated with various aging-related diseases. We examined 415,422 exomes of self-reported White ancestry individuals from the UK Biobank and tested the impact of rare variants, at the level of single variants and through aggregate variant-set tests, on mtDNA-CN. A survey across nine variant sets tested enrichment of putatively causal variants and identified 14 genes at experiment-wide significance and three genes at marginal significance. These included associations at known mtDNA depletion syndrome genes (mtDNA helicase TWNK, p = 1.1 × 10−30; mitochondrial transcription factor TFAM, p = 4.3 × 10−15; mtDNA maintenance exonuclease MGME1, p = 2.0 × 10−6) and the V617F dominant gain-of-function mutation in the tyrosine kinase JAK2 (p = 2.7 × 10−17), associated with myeloproliferative disease. Novel genes included the ATP-dependent protease CLPX (p = 8.4 × 10−9), involved in mitochondrial proteome quality, and the mitochondrial adenylate kinase AK2 (p = 4.7 × 10−8), involved in hematopoiesis. The most significant association was a missense variant in SAMHD1 (p = 4.2 × 10−28), found on a rare, 1.2-Mb shared ancestral haplotype on chromosome 20. SAMHD1 encodes a cytoplasmic host restriction factor involved in viral defense response and the mitochondrial nucleotide salvage pathway, and is associated with Aicardi-Goutières syndrome 5, a childhood encephalopathy and chronic inflammatory response disorder. Rare variants were enriched in Mendelian mtDNA depletion syndrome loci, and these variants implicated core processes in mtDNA replication, nucleoid structure formation, and maintenance. These data indicate that strong-effect mutations from the nuclear genome contribute to the genetic architecture of mtDNA-CN.

27 June 2022 in medRxiv
Verified
Preprint
Open access
PDF file
VPVamsee Pillalamarri
Vamsee Pillalamarri
WSWen Shi
Wen Shi
CSConrad Say
Conrad Say
SYStephanie Yang
Stephanie Yang
JLJohn Lane
John Lane
DADan E. Arking
Dan E. Arking
Inter-individual variation in the number of copies of the mitochondrial genome, termed mitochondrial DNA copy number (mtDNA-CN), reflects mitochondrial function and has been associated with various aging-related diseases. We examined 415,422 exomes of self-reported White ancestry individuals from the UK Biobank and tested the impact of rare variants, both at the level of single variants and through aggregate variant-set tests, on mtDNA-CN. A survey across nine variant sets tested enrichment of putatively causal variants and identified 14 genes at experiment-wide significance and three genes at marginal significance. These included associations at known mitochondrial DNA depletion syndrome genes (mtDNA helicase TWNK , p=5.7×10 −29 ; mitochondrial transcription factor TFAM , p=4.3×10 −13 ; mtDNA maintenance exonuclease MGME1 , p=1.3×10 −6 ) and the V617F dominant gain-of-function mutation in the tyrosine kinase JAK2 (p=7.1×10 −17 ) associated with myeloproliferative disease. Novel genes included the ATP-dependent protease CLPX (p=9.9×10 −9 ) involved with mitochondrial proteome quality and the mitochondrial adenylate kinase AK2 (p=5.3×10 −8 ) involved with hematopoiesis. The most significant association was a missense variant in SAMHD1 (p=4.2×10 −28 ), found on a rare, 1.2 Mb shared ancestral haplotype on chromosome 20. SAMHD1 encodes a cytoplasmic host restriction factor involved with viral defense response and the mitochondrial nucleotide salvage pathway, and is associated with Aicardi-Goutières syndrome 5, a childhood encephalopathy and chronic inflammatory response disorder. Rare variants were enriched in Mendelian mtDNA depletion syndrome loci, and these variants further implicated core processes in mtDNA replication, nucleoid structure formation, and maintenance. Together, these data indicate strong-effect mutations from the nuclear genome contribute to the genetic architecture of mtDNA-CN.